Blogs
Healthcare and Medtech Research Reports
Sep 28, 2026
Summary After years of a stalled pipeline, 2026 brought two major FDA antibiotic approvals, GSK/Spero Therapeutics’ UTEBZI (tebipenem pivoxil) and Wockhardt’s ZAYNICH (cefepime and zidebactam), signaling real progress against drug-resistant infections. Resistant bacteria are turning routine infections into m...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper